NCT07211217

Brief Summary

This is a randomized controlled trial investigating the effects of an 8-TRE intervention compared to a wait list (control) on metabolic health and body composition in people diagnosed with BD and who are currently obese and at least mildly depressed. Following a 1-week baseline assessment, participants will be randomized to either a TRE or the wait list (1-to-1 ratio) for 8 weeks. At baseline, Week 8 (post treatment), and Week 20 (follow-up), investigators will assess daily eating patterns for one week, followed by collection of fasting lipids, body weight and vital signs. At Week 4 (i.e., mid-treatment), the investigators will assess self-reported outcomes only. Participants assigned to the wait list condition will have the option of receiving the TRE intervention after 20 weeks.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
16mo left

Started Jun 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 26, 2025

Completed
11 days until next milestone

First Posted

Study publicly available on registry

October 7, 2025

Completed
8 months until next milestone

Study Start

First participant enrolled

June 1, 2026

Expected
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 30, 2026

1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2027

Last Updated

May 5, 2026

Status Verified

May 1, 2026

Enrollment Period

4 months

First QC Date

September 26, 2025

Last Update Submit

May 4, 2026

Conditions

Keywords

Time Restricted Eating

Outcome Measures

Primary Outcomes (1)

  • Weight Loss

    Body weight will be collected in the fasted state using a digital scale (lbs)

    Week 0, Week 8, Week 20

Secondary Outcomes (8)

  • Patient Health Questionnaire-9 (PHQ-9)

    Week 0, Week 4, Week 8, Week 20

  • Generalized Anxiety Disorder scale (GAD-7)

    Week 0, Week 4, Week 8 and Week 20

  • Pittsburgh Sleep Quality Index (PSQI)

    Week 0, Week 4, Week 8, Week 20

  • Cognitive complaints in bipolar disorder rating assessment (COBRA)

    Week 0, Week 4, Week 8, Week 20

  • Patient-reported Outcome Measurement Information System (PROMIS) Cognitive Function Short Form 8a

    Week 0, Week 4, Week 8, Week 20

  • +3 more secondary outcomes

Study Arms (2)

Time Restrictive Eating Condition

ACTIVE COMPARATOR

TRE is a dietary intervention where participants eat all of their food within a specific 8-hour eating window, for example eating only between 10am and 6pm. Participants will not be asked to change what they eat, only when to eat. Participants will keep a daily Food Timing Log to record the time of the first and last food and drink that they consume each day. The study will ask participants to continue to do this daily throughout the study (\~8 weeks).

Other: Time Restricted Eating

Waitlist Condition

NO INTERVENTION

Participants assigned to the wait list condition will have the option of receiving the TRE intervention after 20 weeks.

Interventions

See arms description

Time Restrictive Eating Condition

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (aged 18-65 years)
  • Diagnosed with bipolar disorder (i.e., subtype Bipolar I or II as assessed with the Quick SCID)21
  • Currently experiencing depression (i.e., PHQ-9 ≥ 10)22
  • Currently overweight (i.e., Body mass index (BMI) \> 30 kg/m2)
  • Provides Informed Consent

You may not qualify if:

  • Dietary factors:
  • Diagnosis, or strong clinical suspicion, of eating disorders, including but not limited to, anorexia nervosa, bulimia nervosa, binge eating disorder (as assessed with the Quick SCID)
  • Concurrent dietary intervention or modification unrelated to study procedures
  • Psychiatric factors:
  • Severe depression (i.e., PHQ-9\>20)
  • Experiencing manic symptoms (i.e., ASRM \< 6)23
  • Active suicidal ideation (i.e., PHQ-9, item 9 \>2)
  • Current alcohol/substance use disorder (as assessed with the Quick SCID)
  • Medical factors:
  • Use of weight loss medications or supplements
  • Use of medications that may cause weight loss or gain, unless body weight and medication usage remained stable for at least 6 months
  • Previous weight loss surgery
  • Malignancy within past 2 years
  • Major surgery within past 3 months
  • Medical instability considered to interfere with study procedures
  • +7 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Bipolar DisorderOverweightIntermittent Fasting

Condition Hierarchy (Ancestors)

Bipolar and Related DisordersMood DisordersMental DisordersOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsFastingFeeding BehaviorBehavior

Study Officials

  • Louisa G. Sylvia, PhD

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Giuliana M Chau

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Waitlist Control Group
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Associate Director

Study Record Dates

First Submitted

September 26, 2025

First Posted

October 7, 2025

Study Start (Estimated)

June 1, 2026

Primary Completion (Estimated)

September 30, 2026

Study Completion (Estimated)

September 30, 2027

Last Updated

May 5, 2026

Record last verified: 2026-05